LEADER 01901nam  22004813u 450 
001 9910463102203321
005 20210113182341.0
010   $a1-78084-252-X
035   $a(CKB)2670000000399344
035   $a(EBL)1179622
035   $a(OCoLC)854971658
035   $a(SSID)ssj0001599916
035   $a(PQKBManifestationID)16306841
035   $a(PQKBTitleCode)TC0001599916
035   $a(PQKBWorkID)14892775
035   $a(PQKB)10283736
035   $a(MiAaPQ)EBC1179622
035   $a(Au-PeEL)EBL1179622
035   $a(EXLCZ)992670000000399344
100   $a20131021d2013||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAdvances in the Management of Ankylosing Spondylitis$b[electronic resource]
205   $a1st ed.
210   $aLondon $cFuture Medicine Ltd$d2013
215   $a1 online resource (121 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-254-6 
327   $aTitle page; Copyright page; Contents; Foreword. Advances in the management of ankylosing spondylitis; 1. A brief history of ankylosing spondylitis; 2. Pathophysiology and symptoms; 3. Diagnosis of ankylosing spondylitis; 4. NSAIDs for spondyloarthrits including ankylosing spondylitis; 5. Targeted therapies: TNF-alpha blockers in the treatment of spondyloarthritides; 6. Targeted therapies: other agents; 7. Outcome measurements in ankylosing spondylitis; 8. Treatment algorithm and prognosis; Index
330   $aAdvances in the Management of Ankylosing Spondylitis
608   $aElectronic books.
700   $aCalin$b Andrei$0918377
702   $aCalin$b Andrei
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910463102203321
996   $aAdvances in the Management of Ankylosing Spondylitis$92441679
997   $aUNINA